IDA blend vs Spain: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- IDA blend
- Spain
How they compare
Spain currently reports 27.6% against 11.5% in IDA blend, a difference of 16.1%.
That makes Spain's figure about 2.4 times IDA blend's.
Across all 9 years both countries report, Spain has been ahead every year.
IDA blend ranks 39th and Spain ranks 39th of 46 groups.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.2% | 33.4% | 11.2% | Spain |
| 2010s | 16.8% | 30.8% | 14.0% | Spain |
| 2020s | 12.1% | 28.0% | 15.9% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, IDA blend or Spain?
- Spain, at 27.6% against 11.5% in IDA blend as of 2024.
- What is the difference in prevalence of current tobacco use between IDA blend and Spain?
- 16.1%, with Spain ahead.
- How many years of comparable data are there for IDA blend and Spain?
- 9 years are reported by both, from 2000 to 2024.
- How do IDA blend and Spain rank globally for prevalence of current tobacco use?
- IDA blend ranks 39th and Spain ranks 39th of 46 groups.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.